Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3383 Target Snapshot

Liver carboxylesterase · SINGLE PROTEIN · Sus scrofa

242Compounds
80Assays
1Approved Drugs
225.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q29550. Use UniProt Q29550 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q29550 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Liver carboxylesterase as ChEMBL target CHEMBL3383, mapped to UniProt Q29550. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Liver carboxylesterase
SINGLE PROTEIN · Sus scrofa
As of 2026-09-13
ChEMBL target ID
CHEMBL3383
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q29550
Liver carboxylesterase
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Liver carboxylesterase is the right protein anchor across sources, using UniProt Q29550 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelLiver carboxylesterase
UniProt AccessionQ29550
Component TypeProtein
Sequence Length566 aa

Liver carboxylesterase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Liver carboxylesterase, mapped to UniProt Q29550. Sequence length is 566 aa.

Mapped IDQ29550
Review nameLiver carboxylesterase
OrganismSus scrofa
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC50206.0
KI19.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL155514 9.34 IC50 0.4571 Preclinical
CHEMBL270374 8.89 IC50 1.3 Preclinical
CHEMBL440542 8.74 IC50 1.8 Preclinical
CHEMBL89506 8.62 IC50 2.4 Preclinical
CHEMBL269931 8.49 IC50 3.2 Preclinical
CHEMBL402615 8.35 IC50 4.5 Preclinical
CHEMBL4854298 8.3 IC50 4.95 Preclinical
CHEMBL4868014 8.29 IC50 5.14 Preclinical
CHEMBL270375 8.28 IC50 5.3 Preclinical
CHEMBL4853742 8.21 IC50 6.14 Preclinical
Distribution

pChEMBL Value Distribution

19
5.0
16
5.5
23
6.0
14
6.5
16
7.0
11
7.5
16
8.0
4
8.5
1
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

ISOFLUROPHATE
CHEMBL1025
Approved 1957
Assay Landscape

Assay Landscape

80
Total Assays
127
Tested Compounds
4
Assay Types
ADME — 44 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 34 1 5.8
tissue-based format 9 0
single protein format 1 0
Binding — 33 assays, 127 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 26 84 6.1
tissue-based format 6 22 7.1
single protein format 1 21 6.6
Unassigned — 2 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 2 0
Physicochemical — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
small-molecule physicochemical format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine